...Assay company MetriGenix acquired GeneXP, a developer of gene expression-based biomarker tests, for an undisclosed sum...
...of gene expression-based biomarker tests, for an undisclosed sum. GeneXP Biosciences Inc. , Woburn, Mass. MetriGenix Inc....

...Deborah Oronzio as VP of business development and marketing, formerly manager of business development at Metrigenix Inc....

...The product is for use with the company's 4D Assay System for DNA assay applications. MetriGenix Inc....

...companies launched the Tm100 Universal Array on MetriGenix's 4D Assay System for DNA assay applications. MetriGenix Inc....

...biomolecule and gene expression analysis. The product includes arrays for cancer, inflammation and neural degeneration. MetriGenix Inc....

...technologies for use with its 4D Assay System biochip technology. TMC is eligible for royalties. MetriGenix Inc....

...Gaithersburg, Md.) received a non-exclusive license from Tm Bioscience (CDNX:TMC) to its Universal Array technologies. MetriGenix...

...market CNS-focused low-density oligonucleotide microarrays. The deal combines human CNS gene information from Neuralstem with MetriGenix’s...
...will be made available to Flow-thru Chip customers for discovery and follow-up screening and validation. MetriGenix Inc....

...Neuralstem (College Park, Md.) and MetriGenix (Gaithersburg, Md.) will collaborate to develop and market CNS-focused low-density...
...market CNS-focused low-density oligonucleotide microarrays. The deal combines human CNS gene information from Neuralstem and MetriGenix's...

...Venture Partners; Axiom Venture Partners; Technology Funding; Javelin Capital; MDS Ventures Pacific; and Sofinnova Ventures. MetriGenix...